CTRI/2021/10/037416尚未招募2 期
Subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after Penetrating Keratoplasty, A Prospective,Open Label,Non Comparative study
SNMedical College0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)patients having 2 or more than 2 quadrant corneal neovascularisation
- •2)patients who developed corneal neovascularisation during F/U ,not responding to conventional medical treatment .
- •3)patients who gave consent to be in follow up.
排除标准
- •1)patients having persistent epithelial defect
- •2)patients who were systemically not fit for subconj Bevacizumab injection;pts with H/O recent attack of M.I.,stroke and uncontrolled Hypertension.
- •3)pregnant female
研究者
相似试验
已完成
不适用
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
已完成
不适用
The intravitreal injection of Bevacizumab for retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000028770Department of Ophthalmology, Shiga University of Medical Science24
尚未招募
不适用
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurityJPRN-UMIN000007465Tokushima university hospital10
尚未招募
不适用
Subtenon injection of bevacizumab for retinal vein occulusioretinal vein occulusionJPRN-UMIN000005254Department of Ophthalmology, Keio University School of Medicine40
招募中
不适用
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesionsJPRN-UMIN000020916Keio University, School of Medicine1,000